Evidence-Based Prescribing: Tools You Can Use to Fight the Opioid Epidemic

Saturday, July 21, 2018

Penn State Health Milton S. Hershey Medical Center
University Conference Center (UCC)
30 Conference Center St.
Hershey, PA 17033


Saturday, Aug. 4, 2018

Penn State College of Medicine
Room C1845, Biomedical Research Building (BMR)
700 HMC Crescent Road
Hershey, PA 17033


Saturday, Aug. 11, 2018

Penn State Health St. Joseph Medical Center
Franciscan Room
2500 Bernville Road (Route 183)
Reading, PA 19601


Saturday, Aug. 25, 2018

Penn State College of Medicine
Room C3621
700 HMC Crescent Road
Hershey, PA 17033


Select this button to navigate the sections of this page

Conference ID

A6343

Overview

Pennsylvania Prescription Drug Monitoring Program (PDMP) System User Training

The Pennsylvania Department of Health PDMP Office, in collaboration with Penn State College of Medicine, invites you to participate.

Purpose

This training is designed to review the PDMP System User Training Modules 2, 3, 6 and 7. Modules 1, 4 and 5 are available through the Pennsylvania Department of Health PDMP resources page.

Audience

All prescribers and other interested health-care professionals are encouraged to attend.

Credit

These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through partnership with the PDMP Office and the University of Pittsburgh School of Medicine. The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All modules can be used to meet the Medical and/or Osteopathic Boards’ CME credit requirement of Patient Safety/Risk Management, and modules 3 to 7 can be used to meet the Act 124 of 2016 opioid education requirements. However, a provider cannot use the same module to meet both the Act 124 and Patient Safety/Risk Management requirements.

The specific requirements that each module meets:

Act 124/Module 2
Patient Safety/Risk Management
What is a PDMP, How to Use the PDMP to Make Clinical Decisions, How to Integrate the PDMP into the Clinical Workflow, and How to Access Pennsylvania’s PDMP

  1. Detail Pennsylvania’s requirements and regulations regarding PDMP use.
  2. Explore options and actions Pennsylvania prescribers and pharmacists can take to integrate the PDMP into clinical workflows.
  3. Discuss how to use the PDMP system to make clinical decisions.

Act 124/Module 3
Pain Management
Using the PDMP to Optimize Pain Management

  1. Learn how to use the PDMP to address pain management for various patient populations and pain types.
  2. Understand the basic nature of pain for different patient populations and how to manage their pain using the PDMP as a clinical tool.
  3. Discuss different ways of treating patient pain that do not involve the immediate use of opioids.

Act 124/Module 6
Identification of Addiction
Approaches to Addressing Substance Use Disorder with Patients Identified by the PDMP

  1. Learn how to integrate the PDMP with other screening tools to help identify those who may require substance use disorder treatment or increased monitoring.
  2. Define Screening, Brief Intervention, and Referral to Treatment (SBIRT), its main goals, and its main components.
  3. Learn how to screen a patient for a potential substance use disorder, conduct a brief intervention, and refer a patient to treatment.
  4. Learn how to discuss a substance use disorder with a patient and handle patient resistance.
  5. Learn how to incorporate SBIRT into clinical practice.

Act 124/Module 7
Prescribing Practices for Opioids
Effective Opioid Tapering Practices

  1. Discuss how to use the PDMP to determine if a provider should consider tapering their patient.
  2. Discuss several indicators that prescribers can look for when considering tapering opioids.
  3. Inform prescribers on how to discuss tapering with patients using patient-centered techniques.
  4. Present a general opioid tapering protocol and how to adapt this protocol to the needs of any patient.
  5. Present information on how to manage withdrawal and how to use tools to measure withdrawal symptoms in patients.

Act 124/Modules 1, 2, 3, 4, 5, 6 and 7
Patient Safety/Risk Management

Agenda

  • 7 a.m. | Check-In and Continental Breakfast
  • 7:30 a.m. | Program Begins
    • Module 2
      What is a PDMP, How to Use the PDMP to Make Clinical Decisions, How to Integrate the PDMP into the Clinical Workflow, and How to Access Pennsylvania’s PDMP
    • Module 3
      Using the PDMP to Optimize Pain Management
    • Module 6
      Approaches to Addressing Substance Use Disorder with Patients Identified by the PDMP
    • Module 7
      Effective Opioid Tapering Practices
  • Noon | Evaluation and Adjournment

Faculty

Expert faculty from Penn State College of Medicine will present the material.

Fee

There is no charge for participation in the Department PDMP System User Training or for the CME credit, however, registration is required.

Cancellation

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund registration fees but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies. Preregistered participants will be notified if a program is filled or canceled.

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Disclosure and Conflict of Interest (COI and educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. A6343

Jump to ...